Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis for the half year ended September 30, 2020. This may be taken as compliance under the Listing Regulations.
04-12-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Results : Financial Results For The Quarter And Half Year Ended 30Th September,2020

 The Board of Directors at its meeting held today, considered and approved the following matters: 1. Unaudited Standalone and Consolidated Financial Results for the Quarter and Half year ended 30th September, 2020. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and Half year ended 30th September, 2020 is enclosed herewith. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended 30th September, 2020 is enclosed herewith. 2. Appointment of Ms. Manjul Sandhu(DIN : 00330363) as an Additional Independent Woman Director Disclosure pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 read with SEBI circular no CIR/CFD/CMD/4/2015 dated 09th September, 2015 is enclosed herewith.
11-11-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Outcome Of The Board Meeting

 The Board of Directors at its meeting held today, considered and approved the following matters: 1. Unaudited Standalone and Consolidated Financial Results for the Quarter and Half year ended 30th September, 2020. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and Half year ended 30th September, 2020 is enclosed herewith. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended 30th September, 2020 is enclosed herewith. 2. Appointment of Ms. Manjul Sandhu(DIN : 00330363) as an Additional Independent Woman Director Disclosure pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 read with SEBI circular no CIR/CFD/CMD/4/2015 dated 09th September, 2015 is enclosed herewith.
11-11-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Board Meeting Intimation for Considering, The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On 30Th September, 2020 On Wednesday, 11Th November, 2020

 THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2020 ,inter alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results for the Quarter and Half year ended on 30th September, 2020
04-11-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances - Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015 For The Half Year Ended 30Th September, 2020

 Enclosed herewith please find Compliance Certificate issued by M/s. V. Laxman & Co Practicing Company Secretaries for the half year ended 30th September, 2020 in terms of Regulation 40(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. This may be taken as compliance under Regulation 40(9) of the Listing Regulations.
29-10-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances -Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements)Regulations, 2015 For The Half Year Ended On September 30, 2020

 Compliance Certificate - Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015 for The Half Year Ended On September 30, 2020
29-10-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2020 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. This is for your information and record.
27-10-2020
Bigul

Themis Medicare Ltd - 530199 - Shareholding for the Period Ended September 30, 2020

 Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
22-10-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Statement Of Investor Complaints For The Quarter Ended September 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sangameshwar IyerDesignation :- Company Secretary and Compliance Officer
21-10-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window

 We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (PIT) Regulations, 2015 (as amended) (PIT Reg) and pursuant to BSE Circular Ref No: LIST/COMP /01/2019-20 dated 02.04.19 and NSE Circular Ref No. NSE/CML/2019/11 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from 1.10, 20 and will re-open after completion of 48 hours from the declaration of financial results for the qtr and half year ended 30.09.2020 by the Board of the Company. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for considering the said financial results for the qtr and half year ended 30.09,20 shall be intimated in due course. We request you to kindly take the above information on record.
30-09-2020
Next Page
Close

Let's Open Free Demat Account